(Q37825527)

23 August 2017

1 reference

title

Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses (English)

1 reference

23 August 2017

1 reference

1 reference

1

Michael Houghton

1 reference

23 August 2017

1 January 2011

1 reference

23 August 2017

Immunological Reviews

1 reference

23 August 2017

239

1 reference

23 August 2017

1

1 reference

23 August 2017

99-108

1 reference

Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection

23 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

Coligation of the hepatitis C virus receptor CD81 with CD28 primes naive T lymphocytes to acquire type 2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.2010.00977.X

Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Protection against persistence of hepatitis C.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Intracellular innate immune cascades and interferon defenses that control hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Neutralizing antibody response during acute and chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

HCV natural history: the retrospective and prospective in perspective

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Adaptive immune responses in acute and chronic hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Characterization of the hepatitis C virus E2/NS1 gene product expressed in mammalian cells

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Cross-genotype immunity to hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Vaccination of chimpanzees against infection by the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Induction of broadly neutralizing H1N1 influenza antibodies by vaccination

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Prospects for a vaccine against the hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Mother-to-infant transmission of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Persistence of HCV despite antibodies to both putative envelope glycoproteins

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Association of hepatitis C virus envelope proteins with exosomes

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Analysis of a successful immune response against hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Role of the specific T-cell response for clearance and control of hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Hepatitis C virus genetic variability: pathogenic and clinical implications

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Induction of broad CD4+ and CD8+ T-cell responses and cross-neutralizing antibodies against hepatitis C virus by vaccination with Th1-adjuvanted polypeptides followed by defective alphaviral particles expressing envelope glycoproteins gpE1 and [...]

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Vaccination against hepatitis B and C: towards therapeutic application

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Characterization of antibodies induced by vaccination with hepatitis C virus envelope glycoproteins.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Patient HLA-DRB1* and -DQB1* allele and haplotype association with hepatitis C virus persistence and clearance.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Characterization of the envelope glycoproteins associated with infectious hepatitis C virus

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

The hepatitis C virus non-structural NS5A protein impairs both the innate and adaptive hepatic immune response in vivo

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Studies of hepatitis C virus in chimpanzees and their importance for vaccine development.

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1600-065X.2010.00977.X

Identifiers

DOI

10.1111/J.1600-065X.2010.00977.X

1 reference

23 August 2017

1 reference

PubMed ID

21198667